6 Einträge gefunden

1. Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors

   1. Hambach, Julia
   2. Mann, Anna Marei
   3. Bannas, Peter
   4. Koch-Nolte, Friedrich

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells

   1. Hambach, Julia
   2. Fumey, William
   3. Stähler, Tobias
   4. Gebhardt, Anna Josephine
   5. Adam, Gerhard
   6. Weisel, Katja
   7. Koch-Nolte, Friedrich

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy

   1. Pape, Luca Julius
   2. Hambach, Julia
   3. Gebhardt, Anna Josephine
   4. Rissiek, Björn
   5. Stähler, Tobias
   6. Tode, Natalie
   7. Khan, Cerusch

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Mouse CD38-Specific Heavy Chain Antibodies Inhibit CD38 GDPR-Cyclase Activity and Mediate Cytotoxicity Against Tumor Cells

   1. Baum, Natalie
   2. Eggers, Marie
   3. Koenigsdorf, Julia
   4. Menzel, Stephan
   5. Hambach, Julia
   6. Staehler, Tobias
   7. Fliegert, Ralf

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD+ Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells

   1. Baum, Natalie
   2. Fliegert, Ralf
   3. Bauche, Andreas
   4. Hambach, Julia
   5. Menzel, Stephan
   6. Haag, Friedrich
   7. Bannas, Peter

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics

   1. Bannas, Peter
   2. Hambach, Julia
   3. Koch-Nolte, Friedrich

   2017 - Forschungsinformationssystem des UKE - frei zugänglich